Anaplastic lymphoma kinase fusion oncogene positive non-small cell lung cancer (Disease Or Phenotype)

Medcin:MEDCIN:414340

Id:459c4b5a-5152-5f73-875c-02762668ba49

Results found

Linked to

	Label	Description
	Ceritinib indication Anaplastic lymphoma kinase fusion oncogene positive non-small cell lung cancer Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h]-[2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile indication Anaplastic lymphoma kinase fusion oncogene positive non-small cell lung cancer Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Brigatinib indication Anaplastic lymphoma kinase fusion oncogene positive non-small cell lung cancer Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Ceritinib indication Anaplastic lymphoma kinase fusion oncogene positive non-small cell lung cancer

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

(10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h]-[2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile indication Anaplastic lymphoma kinase fusion oncogene positive non-small cell lung cancer

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Brigatinib indication Anaplastic lymphoma kinase fusion oncogene positive non-small cell lung cancer

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025